Design of a Novel Integration-deficient Lentivector Technology That Incorporates Genetic and Posttranslational Elements to Target Human Dendritic CellsSemih U. Tareen, Scott H. Robbins, Chintan D. Vin et al.|Molecular Therapy|2013Cited by 32
Abstract 702: DCVex(TM): A novel integration-deficient lentivector technology that incorporates genetic and post-translational elements to target dendritic cellsSemih U. Tareen, Peter Berglund, Jan H. ter Meulen et al.|Cancer Research|2014Cited by 0
PS2-083 Immunization with a novel dc-targeting lentiviral vector induces polyfunctional cd8 t cell responses and therapeutic anti-tumor immunityScott H. Robbins, Thomas W. Dubensky, B. Kelley Clarke et al.|Cytokine|2011Cited by 0